Recombinant Schizosaccharomyces pombe Uncharacterized protein C29A4.17c (SPAC29A4.17c)

What is SPAC29A4.17c and what research tools are available?

SPAC29A4.17c is an uncharacterized protein from Schizosaccharomyces pombe (strain 972 / ATCC 24843, fission yeast). The protein consists of 147 amino acids and is currently available as a recombinant full-length protein with a His-tag, expressed in E. coli . Research tools for studying this protein include polyclonal antibodies raised in rabbit that react specifically with S. pombe SPAC29A4.17c. These antibodies have been tested for applications including ELISA and Western Blotting for protein identification . The antibody product is available in liquid form, stored in a buffer containing 50% glycerol, 0.01M PBS at pH 7.4, with 0.03% Proclin 300 as a preservative .

For protein detection methods, the following protocol parameters are recommended:

What basic experimental approaches should I use to begin characterizing SPAC29A4.17c?

As an uncharacterized protein, initial characterization should follow a systematic approach:

• Expression analysis: Determine when and where the protein is expressed using RT-PCR, Northern blotting, or RNA-seq to analyze mRNA expression patterns under different conditions.

• Subcellular localization: Use GFP or other fluorescent protein tagging approaches similar to those described for other S. pombe proteins to determine cellular localization . Create a C-terminal GFP fusion construct and integrate it into the genome to ensure expression at endogenous levels.

• Deletion analysis: Generate a deletion strain and assess viability and phenotypic changes. Based on systematic deletion analysis approaches used for other S. pombe proteins, analyze cellular morphology, growth rate, stress responses, and cell cycle progression .

• Basic biochemical characterization: Purify the recombinant protein and perform size exclusion chromatography, circular dichroism, and thermal stability assays to gather information about basic structural properties.

• Post-translational modification analysis: Perform mass spectrometry to identify potential phosphorylation, ubiquitination, or other modifications that might provide functional clues.

How can I systematically determine the function of SPAC29A4.17c?

Determining the function of an uncharacterized protein requires a multi-faceted approach:

• Bioinformatic analysis:

  • Perform homology searches using BLAST, PSI-BLAST, and HHpred

  • Conduct structural prediction using AlphaFold2 or similar tools

  • Identify conserved domains and motifs

  • Perform phylogenetic analysis to identify orthologs in other species

• Transcriptomic profiling:

  • Compare gene expression signatures of deletion mutants with known mutants to identify clustered expression patterns

  • As demonstrated in studies of other S. pombe proteins, expression signatures can cluster mutants with similar functions, providing functional hints

• Synthetic genetic interactions:

  • Perform synthetic genetic array (SGA) analysis by crossing the deletion mutant with a library of viable deletion mutants

  • Identify genetic interactions that suggest pathway participation

• Proteomic approaches:

  • Perform affinity purification followed by mass spectrometry (AP-MS) to identify interaction partners

  • Use proximity labeling approaches like BioID or APEX to identify proximal proteins

• Phenotypic characterization under varied conditions:

  • Test sensitivity to various stressors (temperature, oxidative stress, DNA damage, etc.)

  • Examine cell morphology and nuclear DNA organization as performed for other S. pombe proteins

What approaches can I use to investigate potential involvement of SPAC29A4.17c in specific cellular pathways?

To investigate pathway involvement, consider the following methodological approaches:

• Epistasis analysis:

  • Create double mutants with genes in suspected pathways

  • Determine if phenotypes are additive, synergistic, or suppressive

• Response to pathway inhibitors:

  • Test sensitivity of deletion mutants to specific inhibitors of major cellular pathways

  • Compare responses to those of known pathway component mutants

• Pathway-specific reporter assays:

  • Use reporters for major signaling pathways (stress response, cell cycle, etc.)

  • Monitor pathway activation in wild-type versus deletion backgrounds

• Phosphoproteomic analysis:

  • Compare phosphorylation changes in deletion mutants versus wild-type

  • Identify affected signaling networks

• Conditional expression systems:

  • Create strains with regulatable expression (e.g., nmt1 promoter variants)

  • Analyze consequences of protein depletion or overexpression

The systematic approach used for fission yeast protein kinases provides an excellent methodological framework applicable to SPAC29A4.17c characterization .

How should I design experiments to analyze phenotypes of SPAC29A4.17c deletion mutants?

Phenotypic analysis should be comprehensive and quantitative:

• Growth analysis:

  • Measure growth rates in liquid culture under standard conditions

  • Perform serial dilution spot tests on various media types

  • Test temperature sensitivity (25°C, 30°C, 36°C)

• Microscopic analysis:

  • Examine cell morphology (length, width, septation index)

  • Analyze nuclear morphology using DAPI staining (similar to analysis performed for SPCC70.05c mutants)

  • Check for defects in cell polarity, cell wall integrity, and cytokinesis

• Cell cycle analysis:

  • Perform flow cytometry to analyze DNA content

  • Use cell cycle markers to determine progression rates

  • Synchronize cultures and monitor division timing

• Stress response assessment:

  • Test sensitivity to osmotic stress (KCl, sorbitol)

  • Evaluate oxidative stress responses (H₂O₂, menadione)

  • Examine DNA damage sensitivity (UV, MMS, HU)

• Specialized phenotypic tests:

  • Assess mating efficiency and sporulation

  • Test for specific organelle defects

  • Evaluate membrane trafficking

For documentation, use standardized scoring systems for phenotypic analysis similar to those employed in the systematic deletion analysis of fission yeast protein kinases :

How can I determine if SPAC29A4.17c is essential for viability?

To determine essentiality, follow these methodological steps:

• Heterozygous diploid deletion:

  • Create a heterozygous diploid with one SPAC29A4.17c allele deleted

  • Induce sporulation and perform tetrad analysis

  • Analyze the viability pattern of spores (2:2 viable:non-viable pattern suggests essentiality)

• Conditional expression system:

  • Replace the endogenous promoter with a regulatable promoter (e.g., nmt1)

  • Repress expression and assess viability

  • Monitor cellular phenotypes during protein depletion

• Analog-sensitive mutants:

  • If SPAC29A4.17c has potential enzymatic activity, create analog-sensitive mutants

  • Use chemical genetics approaches to acutely inhibit protein function

• Auxin-inducible degron system:

  • Tag the protein with an AID tag

  • Rapidly deplete the protein upon auxin addition

  • Monitor immediate consequences

Based on the methodological framework used in systematic deletion analysis of fission yeast proteins, essentiality can be rigorously established through multiple approaches .

What experimental approaches can I use to determine the subcellular localization of SPAC29A4.17c?

To determine subcellular localization, implement these methodological approaches:

• Fluorescent protein tagging:

  • Create C-terminal GFP fusions at the endogenous locus

  • Similar to localization studies performed for other S. pombe proteins (SPCC70.05c-GFP, SPBC17F3.02-GFP, and SPBC32H8.10-GFP)

  • Verify functionality of the fusion protein

  • Image during various cell cycle stages and growth conditions

• Immunofluorescence microscopy:

  • Use available antibodies for immunolocalization

  • Co-stain with markers for specific organelles

  • Perform in both fixed and live cells when possible

• Subcellular fractionation:

  • Separate cellular components by differential centrifugation

  • Perform Western blotting to detect protein in different fractions

  • Compare with known markers for various compartments

• Time-lapse imaging:

  • Monitor dynamic localization throughout the cell cycle

  • Assess responses to various stressors or treatments

• Super-resolution microscopy:

  • Use techniques like STORM or PALM for high-resolution localization

  • Determine precise spatial organization

Example documentation of localization patterns should include:

What methods should I use to identify protein interaction partners of SPAC29A4.17c?

To identify interaction partners, use these methodological approaches:

• Affinity purification coupled with mass spectrometry (AP-MS):

  • Express tagged versions of SPAC29A4.17c (His-tag, TAP-tag, or FLAG-tag)

  • Purify under native conditions to maintain interactions

  • Identify co-purifying proteins by mass spectrometry

  • Use appropriate controls to filter out non-specific interactions

• Yeast two-hybrid screening:

  • Use SPAC29A4.17c as bait against a S. pombe cDNA library

  • Validate positive interactions with secondary assays

  • Consider both N and C-terminal fusions to avoid interference with interactions

• Proximity labeling:

  • Fuse SPAC29A4.17c with BioID or APEX2

  • Label proximal proteins in living cells

  • Identify labeled proteins by mass spectrometry

• Co-immunoprecipitation:

  • Use antibodies against SPAC29A4.17c for pulldown experiments

  • Verify interactions with suspected partners

  • Test interactions under different conditions

• In vitro binding assays:

  • Express and purify recombinant SPAC29A4.17c

  • Perform pulldown assays with candidate interactors

  • Use techniques like Surface Plasmon Resonance to quantify interactions

Interaction data should be presented in networks and validated using multiple methods:

How can I use transcriptomic analysis to gain insights into SPAC29A4.17c function?

Transcriptomic analysis can provide functional insights through these methodological approaches:

• Differential expression analysis:

  • Compare gene expression profiles between wild-type and SPAC29A4.17c deletion mutants

  • Identify significantly up- or down-regulated genes

  • Perform Gene Ontology enrichment analysis on affected genes

• Expression signature comparison:

  • Compare expression signatures with those of known mutants

  • Use clustering approaches to identify functional relationships

  • This approach has successfully grouped functionally related kinase mutants in S. pombe (e.g., stress response mutants Δsty1, Δwis4, and Δwin1)

• Condition-specific transcriptomics:

  • Analyze expression changes under various stressors or growth conditions

  • Identify condition-specific regulatory roles

  • Compare responses to those of known regulatory mutants

• Time-course analysis:

  • Monitor expression changes during cell cycle progression

  • Analyze meiotic gene expression changes

  • Identify temporal patterns suggesting regulatory functions

• Single-cell RNA-seq:

  • Characterize cell-to-cell variability in gene expression

  • Identify potential heterogeneous responses

Based on methodologies used for other S. pombe proteins, expression signature clustering can reveal functional relationships between seemingly unrelated proteins .

How should I approach resolving contradictory experimental results when studying SPAC29A4.17c?

When facing contradictory results, implement this methodological framework:

• Systematic validation:

  • Verify strain backgrounds and eliminate potential suppressors

  • Confirm genetic modifications by PCR and sequencing

  • Validate antibody specificity with appropriate controls

  • Create multiple independent isolates to ensure reproducibility, as recommended in systematic deletion studies

• Condition-dependent effects:

  • Test multiple growth conditions and stressors

  • Assess whether contradictions are condition-specific

  • Consider media composition, temperature, and growth phase

• Quantitative analysis:

  • Move beyond qualitative observations to quantitative measurements

  • Use statistical approaches to assess significance of differences

  • Ensure adequate sample sizes and appropriate controls

• Orthogonal methods:

  • Confirm key findings with independent methodological approaches

  • Use both genetic and biochemical techniques

  • Implement complementary imaging and molecular methods

• Consideration of indirect effects:

  • Evaluate whether observed phenotypes are direct or indirect

  • Implement acute depletion or inhibition strategies

  • Use time-resolved approaches to distinguish primary and secondary effects

A systematic approach to resolving contradictions follows similar principles to those used in comprehensive deletion analysis studies, which include validation with multiple isolates and multiple methodological approaches .